THERA patient support® Program

There for you and your patients every step of the way

THERA patient support® is a personalized patient support program for healthcare providers and patients. Enroll your patients so they will receive the support they need throughout their EGRIFTA WRTM treatment journey.

By streamlining treatment access and removing barriers to care, THERA patient support® is here to support you, your staff, and your patients every step of the way.

Personalized support for your patients

Coverage and insurance support

Provide comprehensive support for insurance coverage including verification of benefits, assistance with prior authorizations, guidance through the appeals process, and education on payer requirements.

Financial Assistance Program to help cover the cost of care*

Commercial Insurance

The THERA EGRIFTA WRTM Co-Pay Program may help patients with private or commercial insurance lower their out-of-pocket costs.

Government Insurance

THERA patient support® can assist with alternative funding for patients with government insurance that may lower their out-of-pocket costs.

Patient Assistance Program

The THERA Patient Assistance Program offers qualifying patients THERA medications at no cost.

* The Financial Assistance Program is available only for eligible patients.

Injection training with a THERA Nurse Navigator

Guaranteed personalized injection training by one of our experienced THERA patient support® Nurse Navigators. Training is available virtually through telephone or video calls.

Meet the THERA Team

Get to know the dedicated professionals on the THERA patient support® team who support you and your patients throughout their THERA journey.

THERA Patient Care Coordinators

  • Serve as the primary contact for you and your patients once your patients are enrolled in the THERA patient support® program
  • Provide patients with a welcome call, a free sharps container, and the EGRIFTA WRTM Patient Resource Kit
  • Verify insurance coverage and reimbursement solutions
  • Assist with prior authorization and claim denials/appeals
  • Enroll eligible patients in the EGRIFTA WRTM Co-Pay Assistance Program
  • Explore other financial assistance programs and resources

THERA Field Reimbursement Managers

  • Serve as the primary contact for you and your staff
  • Answer questions about the THERA patient support® program
  • Help address and solve reimbursement challenges
  • Educate on payer coverage criteria and policy updates
  • Assist with prior authorization and claim denials/appeals

THERA Nurse Navigators

Our professionally trained and experienced THERA patient support® Nurse Navigators are your patients’ dedicated teammate throughout their EGRIFTA WRTM treatment journey. The THERA Nurse Navigators provide patients enrolled in the THERA patient support® program with personalized one-on-one nursing support. THERA Nurse Navigators will:

  • Welcome patients into the THERA patient support® program and coordinate calls or virtual meetings
  • Train patients on reconstituting and administering EGRIFTA WRTM
  • Help patients set realistic treatment goals and expectations
  • Facilitate patient adherence through scheduled one-on-one touchpoints
  • Support answering any product-related questions

Remind your patients to save 1-833-23THERA (1-833-238-4372)—the THERA patient support® number—in their contacts to ensure they never miss important updates and always know who is calling.

Explore THERA patient support® resources

THERA patient support® HCP Brochure

A comprehensive summary of the services offered by the THERA patient support® program to you and your patients on EGRIFTA WRTM therapy.

THERA patient support® Patient Brochure

A comprehensive patient guide on the services offered by the THERA patient support® program to support them on their EGRIFTA WRTM treatment journey.

Visit the THERA patient support® website to access enrollment forms, coverage access forms, and other helpful resources for the THERA patient support® program.

Visit the THERA patient support® Physician Portal to seamlessly enroll patients online, upload the signed patient consent form and chart notes, track patients’ real-time enrollment status, obtain coverage information, and view the EGRIFTA WRTM shipment information.

Questions about THERA patient support® services?

Call THERA patient support® program toll free at 1-833-23THERA (1-833-238-4372) and a THERA Patient Care Coordinator will assist you and your office staff. Available Monday to Friday from 8:30 a.m. – 8:00 p.m. EST.

Let’s keep in touch

Enter your contact details to stay up to date with the latest developments from Theratechnologies.

By clicking the “Sign up” button below, I consent to receiving communications from Theratechnologies.

* Mandatory field.

Thank You for Signing Up!

We look forward to keeping you informed with the latest news and updates from Theratechnologies.

IMPORTANT SAFETY INFORMATION ABOUT EGRIFTA WRTM (TESAMORELIN) FOR INJECTION

Indication

EGRIFTA WRTM is indicated for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy.

Limitations of Use:

  • The impact and safety of EGRIFTA WRTM on cardiovascular health has not been studied.
  • EGRIFTA WRTM is not indicated for weight loss management.
  • It is not known whether taking EGRIFTA WRTM helps improve compliance with anti-retroviral medications.

Contraindications:

Do not use EGRIFTA WRTM if patient:

  • Has a pituitary gland tumor, has had pituitary gland surgery, has other problems related to their pituitary gland, or has had radiation treatment to their head or a head injury.
  • Has active cancer.
  • Is allergic to tesamorelin or any of the ingredients in EGRIFTA WRTM.
  • Is pregnant or planning to become pregnant.

Warnings and Precautions

  • Increased risk of neoplasms: Preexisting malignancy should be inactive and its treatment complete prior to starting EGRIFTA WRTM. EGRIFTA WRTM should be discontinued if the patient has evidence of recurrent malignancy.
  • Elevated IGF-1: Regularly monitor IGF-1 levels in all patients during EGRIFTA WRTM therapy. Consider discontinuing in patients with persistent elevations (e.g., >3 SDS).
  • Fluid retention: May include edema, arthralgia, and carpal tunnel syndrome.
  • Glucose intolerance or diabetes mellitus: May develop with EGRIFTA WRTM treatment. Evaluate glucose status prior to and during therapy with EGRIFTA WRTM.
  • Hypersensitivity reactions: Advise patients to seek immediate medical attention if suspected.
  • Injection site reactions: Advise patients to rotate sites to different areas of the abdomen to decrease injection site reactions.
  • Increased mortality in patients with acute critical illness: Consider discontinuation in critically ill patients.

Drug Interactions

  • EGRIFTA WRTM had no significant impact on the pharmacokinetic profiles of simvastatin in healthy subjects.
  • Monitor patients for potential interactions when administering EGRIFTA WRTM in combination with other drugs known to be metabolized by CYP450 liver enzyme.
  • Patients on glucocorticoids may require dosage adjustment upon initiation of EGRIFTA WRTM.

Use in Specific Populations

  • Lactation: Mothers should not breastfeed if they receive EGRIFTA WRTM.
  • Pediatric use: Safety and effectiveness in pediatric patients have not been established.
  • Geriatric use: There is no information on the use of EGRIFTA WRTM in patients greater than 65 years of age.

Adverse Reactions

The most commonly reported adverse reactions include injection site reactions, arthralgia, pain in extremity, myalgia, and peripheral edema.

For complete disclosure of EGRIFTA WRTM product information, please read the Full Prescribing Information, Patient Information, and Patient Instructions for Use.

For more information about EGRIFTA WRTM, contact THERA patient support® program toll-free at 1-833-23THERA (1-833-238-4372). To report suspected adverse reactions, contact THERA patient support® program or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.